| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.099 | 0.08 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.092 | 0.08 |